BDBM42285 (R)-2-(4-(5-((6-(1-(2-fluoroethyl)-1H-pyrazol-4-yl)pyridin-3-yl)ethynyl)pyrimidin-2-yl)-2-(methoxymethyl)piperazin-1-yl)-1,3,5-triazine::WO2024186584, Example 47

SMILES FCCN1N=CC(=C1)C1=CC=C(C=N1)C#CC=1C=NC(=NC1)N1C[C@@H](N(CC1)C1=NC=NC=N1)COC

InChI Key InChIKey=OTNSMZRSMCHOSW-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 42285   

TargetAlpha-synuclein(Human)
Galderma Research & Development

US Patent
LigandChemical structure of BindingDB Monomer ID 42285BDBM42285((R)-2-(4-(5-((6-(1-(2-fluoroethyl)-1H-pyrazol-4-yl...)
Affinity DataKi:  0.694nMAssay Description:Emory Chemistry-Biology Discovery Center Assay Overview: MLSCN Grant: 1 X01MH78953-01 Hsp90 is a chaperon with important roles in maintaining transfo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/23/2026
Entry Details
US Patent